- Report
- March 2025
- 227 Pages
Global
From €2209EUR$2,500USD£1,934GBP
- Report
- November 2025
- 160 Pages
Global
From €2967EUR$3,358USD£2,598GBP
€3491EUR$3,950USD£3,056GBP
- Report
- December 2025
United States
From €3526EUR$3,990USD£3,087GBP
- Report
- December 2025
Europe
From €3526EUR$3,990USD£3,087GBP
- Report
- December 2025
Middle East
From €3526EUR$3,990USD£3,087GBP
- Report
- December 2025
Asia Pacific
From €3526EUR$3,990USD£3,087GBP
- Report
- August 2025
- 185 Pages
Global
From €3133EUR$3,545USD£2,743GBP
€3481EUR$3,939USD£3,047GBP
- Report
- December 2025
- 268 Pages
Global
From €4816EUR$5,450USD£4,216GBP
- Report
- April 2025
- 250 Pages
Global
From €3968EUR$4,490USD£3,474GBP
- Report
- April 2023
- 120 Pages
Global
From €4198EUR$4,750USD£3,675GBP
- Report
- December 2025
China
From €3526EUR$3,990USD£3,087GBP
- Report
- December 2025
United Kingdom
From €3526EUR$3,990USD£3,087GBP
- Report
- December 2025
Global
From €3526EUR$3,990USD£3,087GBP
- Report
- December 2025
North America
From €3526EUR$3,990USD£3,087GBP
- Report
- December 2025
Europe
From €1851EUR$2,095USD£1,621GBP
€3526EUR$3,990USD£3,087GBP
The Blood Grouping Reagent market is a subset of the Blood Banking industry. It is composed of products used to identify the ABO and Rh blood group of a patient. These reagents are used to determine the compatibility of a patient's blood with a potential donor's blood, and are essential for successful transfusions. The market is composed of a variety of reagents, including monoclonal and polyclonal antibodies, lectins, and enzymes. These reagents are used in a variety of tests, such as agglutination, precipitation, and ELISA.
The Blood Grouping Reagent market is highly competitive, with a number of companies offering a wide range of products. Some of the major players in the market include Immucor, Grifols, Ortho Clinical Diagnostics, Bio-Rad Laboratories, and DiaMed. Show Less Read more
